Panda Surgical secures £1M investment to advance their next-generation neurosurgical robotics platform
London, UK — September 26th, 2025 – Panda Surgical, developer of handheld robots for minimally invasive neurosurgery, today announced the closing of a strategic investment round led by Oxford Investment Consultants (Oxford, UK) and participated by New Wave Ventures (London, UK), experienced UK venture capital firms with a proven track record of supporting breakthrough medical technologies. Joining these two firms were UCL Business, the commercialisation company of UCL which helped establish the company in 2022, as well as US and European neurosurgeons and operators.
The Panda Surgical system is a novel handheld robotic platform with detachable wristed instruments as small as 3mm in diameter. By combining robotic dexterity with the familiarity of handheld tools, the platform aims to enable more neurosurgeons to perform complex procedures in the brain and spine.
"This investment reflects the strong confidence our investors have in our technology, team, and mission." said Manios Dimitrakakis, CEO and co-founder of Panda Surgical, Honorary Research Fellow at University College London’s Dept of Med Phys & Biomedical Engineering. "With their support, we are positioned to bring transformative tools to neurosurgeons and expand access to advanced surgical care for patients worldwide."
Hector Edwards, Associate at Oxford Investment Consultants and now Board Director at Panda Surgical added “We are very excited to be supporting Panda. It has a great team, exciting technology and real passion to transform neurosurgery for the better. We think they are on the way to succeeding with that.”
This new funding will be used to accelerate the company’s upcoming first-in-human clinical investigation and support the development of its cutting-edge handheld robotic platform designed for confined space surgeries.
This financing follows a series of recent milestones, including a strong patent portfolio, worldwide cadaver labs and successful animal trials in Paris.
About Panda Surgical
Panda Surgical, a University College London spinout, is developing the world’s first dexterous robot for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support making these complex operations safer, more effective, and more widely adopted.
For further information, please contact: contact@panda-surgical.com
